Welcome to the first of the EURETINA Debate Series, which took place on Monday 29 April, 2021.
Our first debate handles the questions of: “What have we learnt from the COVID-19 pandemic when it comes to treatment of neovascular AMD: Are fixed regimens the answer or should we take a treat and extend approach?”
In this 60-minute live debate, we hear from Professor Adnan Tufail and Professor Paolo Lanzetta. This EURETINA Debate was moderated by Professor Anat Loewenstein and Professor Frank G. Holz.
Please enjoy this webinar playback, available to all members and non-members, free of charge. This webinar forms part of the EURETINA year-long digital events programme. See the current programme here. Programme events are generally available for anyone to sign up to and will be available for public viewing for a 2-week period following the live event. After this period, only EURETINA Members will be able to access the playback archive. Learn more about membership here.